IPP Bureau

Thermo Fisher Scientific realigns product portfolio
Thermo Fisher Scientific realigns product portfolio

By IPP Bureau - November 02, 2021

Consolidation of the Acros Organics, Alfa Aesar and Maybridge brands to one single brand, Thermo Scientific

AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma
AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma

By IPP Bureau - November 02, 2021

The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio

Built-for-purpose offering for biomolecule attribute monitoring
Built-for-purpose offering for biomolecule attribute monitoring

By IPP Bureau - November 02, 2021

The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity

SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers
SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers

By IPP Bureau - November 02, 2021

New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation

Caplin Point Labs posts  Q2FY22 PAT at Rs 74.98 Cr
Caplin Point Labs posts Q2FY22 PAT at Rs 74.98 Cr

By IPP Bureau - November 02, 2021

The Board of Directors of Caplin Point Laboratories at its meeting have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021

Lyka Labs  Q2FY22 consolidated PAT at Rs. 28.43Cr
Lyka Labs Q2FY22 consolidated PAT at Rs. 28.43Cr

By IPP Bureau - November 01, 2021

Lyka Labs has reported consolidated financial results for the period ended September 30, 2021

GlaxoSmithKline posts Q2FY22 consolidated PAT at  Rs. 204.24 Cr
GlaxoSmithKline posts Q2FY22 consolidated PAT at Rs. 204.24 Cr

By IPP Bureau - November 01, 2021

GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021

Dr Reddys Laboratories  posts Q2FY22 PAT at Rs 992 Cr
Dr Reddys Laboratories posts Q2FY22 PAT at Rs 992 Cr

By IPP Bureau - November 01, 2021

Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021

Dr. Reddy's launches Ephedrine Sulfate injection in the US
Dr. Reddy's launches Ephedrine Sulfate injection in the US

By IPP Bureau - November 01, 2021

The Akovaz brand and generic market had U.S. sales of approximately US $ 67.5 million MAT for the most recent twelve months ending in August 2021

Glamyo Health widens its dental treatment portfolio
Glamyo Health widens its dental treatment portfolio

By IPP Bureau - November 01, 2021

Clear aligners are a series of tight-fitting custom-made mouthpieces or orthodontic systems that are useful in correcting misaligned or crooked teeth

EMA encourages companies to submit type I variations by end- November
EMA encourages companies to submit type I variations by end- November

By IPP Bureau - November 01, 2021

Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021

Samsung Receives FDA clearance for AI algorithms detecting lung nodules in X-rays
Samsung Receives FDA clearance for AI algorithms detecting lung nodules in X-rays

By IPP Bureau - November 01, 2021

It provides an option to automatically perform nodule detection immediately after chest X-ray imaging

Sun Pharma's Winlevi available in the US
Sun Pharma's Winlevi available in the US

By IPP Bureau - November 01, 2021

It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years

Holborn Wells and SpeedBio India forms JV to manufacture in vitro diagnostics
Holborn Wells and SpeedBio India forms JV to manufacture in vitro diagnostics

By IPP Bureau - November 01, 2021

Both parties are expected to invest a total of US $ 1 million to establish the brand

Laurus Labs PAT at Rs 201.90 cr. in Q2FY21
Laurus Labs PAT at Rs 201.90 cr. in Q2FY21

By IPP Bureau - October 29, 2021

Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021

Latest Stories

Interviews

Packaging